Search this site
Embedded Files
Skip to main content
Skip to navigation
The Sharma Lab
Bio
Research
People
Scholarly Work
Funding
Moments
Interviews & Media
Contact Us
The Sharma Lab
Bio
Research
People
Scholarly Work
Funding
Moments
Interviews & Media
Contact Us
More
Bio
Research
People
Scholarly Work
Funding
Moments
Interviews & Media
Contact Us
Interviews & Media
Media Interviews
Media Interview
News Articles
UNTHSC Scientist Shoots for the Stars with Device to Study Eye Damage in Astronauts
A $321,000 grant is helping Dr. Tasmeen Sharma use her patent-pending device to study a condition affecting astronauts returning from outer space. Her startup could help the rest of us, too.
Researcher studies the impact of space on the human eye
Vision loss is one of the risks astronauts face when they return from space flights
Translaminar Autonomous System – a human ground-based analog
Spaceflight-Associated Neuro-ocular Syndrome (SANS) is a significant unexplained adverse reaction to long-duration missions. We employ an ex vivo Translaminar Autonomous System to recreate a human ocular ground-based spaceflight analogue model to study SANS pathogenesis.
New research aims to develop novel therapeutic for glaucoma
INDIANAPOLIS—Researchers at Indiana University School of Medicine are using a novel approach to hopefully develop a new therapy for glaucoma, a complex disease that eventually leads to blindness, thanks to a new five-year, $2 million R01 grant from the National Eye Institute.
Dr. Tasneem Sharma from Indiana University's Glick Eye Institute awarded $70,000 Knights Templar Foundation Grant for Childhood Glaucoma Research — Knights Templar Eye Foundation
Childhood glaucoma is a pediatric condition leading to significant visual impairment. Juvenile-onset primary open angle glaucoma (JOAG) is a subtype of primary glaucoma, and the disease presents from four years to early adulthood. The disease is identified by increased pressure within the eye and pr
Translational Research Institute for Space Health Research
Learn more about the research that has been funded and the investigators helping pave the way for humans to thrive as they travel in deep space....
To the Moon, Mars and Beyond: IU researcher studying ways to prevent and treat common vision loss syndrome in astronauts during long space missions
In July 1969, Neil Armstrong became the first astronaut to walk on the moon. The Apollo 11 mission lasted about four days. Now over 50 years later, astronauts are making much longer trips into space and looking ahead to the potential for even lengthier space flights that could keep astronauts in space for months and years at a time.
A Brighter Outlook for Glaucoma Patients - Ivanhoe Broadcast News, Inc.
Glaucoma is a disease caused by pressure within the eye. Over time, it can lead to vision loss or even blindness. In the U.S., about three million people are affected by it. There is no cure, but researchers are working to develop a new therapy that could give people with glaucoma a better outlook.
Podcasts
All eyes on space
Spaceflight Associated Neuro-ocular Syndrome impairs astronauts’ vision, but new strategies to study the condition in space and on Earth may lead to treatments.
Google Sites
Report abuse
Page details
Page updated
Google Sites
Report abuse